xenoport.com

Xenoport, Inc.

Xenoport, Inc.'s email is bd@xenoport.com and Xenoport, Inc.'s phone number is 14086167210 .

XenoPort, Inc. is a biopharmaceutical company focused on developing and commercializing a portfolio of internally discovered product candidates for the potential treatment of neurological disorders. Horizant® (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in the United States by XenoPort. Regnite® (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in Japan by Astellas Pharma Inc. XenoPort holds all other world-wide rights to gabapentin enacarbil. XenoPort's pipeline of product candidates includes potential treat...

read more

XenoPort, Inc. is a biopharmaceutical company focused on developing and commercializing a portfolio of internally discovered product candidates for the potential treatment of neurological disorders. Horizant® (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in the United States by XenoPort. Regnite® (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in Japan by Astellas Pharma Inc. XenoPort holds all other world-wide rights to gabapentin enacarbil. XenoPort's pipeline of product candidates includes potential treatments for patients with Parkinson's disease, relapsing-remitting multiple sclerosis and psoriasis.

show less

View Top Employees for Xenoport, Inc.
img Website xenoport.com
img Industry Pharmaceuticals
img Location United States
img Employees 132
img Founded 1999
img HQ 3410 Central Expressway
img Phone 1408-616-7210
img Email bd@xenoport.com
img Funding 143,770,000 USD
img Competitors Walgreens Boots Allia..., Pfizer, Cvs Health, Novartis, Gsk, Bayer,
img Website xenoport.com
img Industry Pharmaceuticals
img Location United States
img Employees 132
img Founded 1999
img LinkedIn linkedin.com/company/xenoport
img HQ 3410 Central Expressway
img Phone 1408-616-7210
img Email bd@xenoport.com
img Funding 143,770,000 USD

Top Xenoport, Inc. Employees